Forbes November 9, 2023
Arthur L. Kellermann

Concerns about the safety of over-the-counter eyedrops resurfaced last month when the FDA issued a warning to consumers to avoid using more than two dozen eyecare products due to bacterial contamination at their manufacturing plants. But this wasn’t a newly discovered risk.

The first news of a serious outbreak of eye infections caused by a highly drug-resistant strain of bacteria was reported by the CDC’s Health Alert Network on February 1, 2023. Laboratory testing determined that artificial tears were the source. Although the contaminated product was swiftly pulled from the market, the outbreak ultimately infected 81 people in 18 states. Fourteen lost their vision and four died.

The FDA responded by boosting inspections of overseas manufacturing plants, which had sharply...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, FDA, Govt Agencies, Medical Devices, Pharma, Pharma / Biotech
Who’s Leading the FDA’s AI Race? Top Medical Specialties and Companies to Watch
FDA issues flu vaccine recommendations: 5 respiratory updates
5 Digital Health Areas To Be Impacted By The FDA Layoffs
FDA Approves First Biosimilar to Omalizumab
Trump's Nominees to Run FDA, NIH Get Greenlighted by Senate Committee

Share This Article